| Phase I study of the poly (ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors R Plummer, C Jones, M Middleton, R Wilson, J Evans, A Olsen, N Curtin, ... Clinical cancer research 14 (23), 7917-7923, 2008 | 488 | 2008 |
| Climate change 2013: the physical science basis. Contribution of Working Group I to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change P Ciais, C Sabine, G Bala, L Bopp, V Brovkin, J Canadell, A Chhabra, ... Cambridge University Press, 2013 | 327 | 2013 |
| Carbon and other biogeochemical cycles. Climate change 2013: the physical science basis. Contribution of Working Group I to the Fifth Assessment Report of the Intergovernmental … P Ciais, C Sabine, G Bala, L Bopp, V Brovkin, J Canadell, A Chhabra, ... Cambridge: Cambridge University Press, 2013 | 323 | 2013 |
| Temozolomide Pharmacodynamics in Patients with Metastatic Melanoma: DNA Damage and Activity of Repair Enzymes O6-Alkylguanine Alkyltransferase and … ER Plummer, MR Middleton, C Jones, A Olsen, I Hickson, P McHugh, ... Clinical cancer research 11 (9), 3402-3409, 2005 | 117 | 2005 |
| The physical science basis. Contribution of working group I to the fifth assessment report of the intergovernmental panel on climate change P Ciais, C Sabine, G Bala, L Bopp, V Brovkin, J Canadell, A Chhabra, ... Change, IPCC climate 10, 2013 | 109 | 2013 |
| Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules J Murray, H Thomas, P Berry, S Kyle, M Patterson, C Jones, G Los, ... British journal of cancer 110 (8), 1977-1984, 2014 | 64 | 2014 |
| First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors R Plummer, M Middleton, R Wilson, C Jones, J Evans, L Robson, ... Journal of Clinical Oncology 23 (16_suppl), 3065-3065, 2005 | 57 | 2005 |
| Therapeutic combinations comprising poly (ADP-ribose) polymerases inhibitor HM Steinfeldt, TJ Boritzki, AH Calvert, NJ Curtin, MR Dewji, Z Hostomsky, ... US Patent App. 11/231,470, 2006 | 44 | 2006 |
| PARP inhibitors and cancer therapy—early results and potential applications C Jones, ER Plummer The British Journal of Radiology 81 (special_issue_1), S2-S5, 2008 | 27 | 2008 |
| Assessing the application of trace metals as paleoproxies and a chemostratigraphic tool in carbonate systems: A case study from the “Mississippian Limestone” of the … JW Steinmann, GM Grammer, B Brunner, CK Jones, N Riedinger Marine and petroleum geology 112, 104061, 2020 | 16 | 2020 |
| Benthic iron flux influenced by climate‐sensitive interplay between organic carbon availability and sedimentation rate in Arctic fjords LC Herbert, Q Zhu, AB Michaud, K Laufer‐Meiser, CK Jones, N Riedinger, ... Limnology and Oceanography 66 (9), 3374-3392, 2021 | 12 | 2021 |
| Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly (ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with … ER Plummer, M Middleton, R Wilson, J Evans, C Jones, A Olson, ... AACR/NCI/EORTC International Conference on Molecular Targets and Cancer …, 2005 | 10 | 2005 |
| The Updated Version of SF Box: A method for soil quality classification as a basis for applicable site-specific environmental risk assessment of contaminated soils Y Volchko, L Rosén, C Jones, M Viketoft, A Herrmann, S Dahlin, ... | 5 | 2019 |
| Factors affecting human tactile response to wash-treated garments: analysis of fabric and garment effects in dynamic wear R Barker, A Bernard, D Hinks, G Liston, C Jones, S Singleton AATCC Journal of Research 1 (1), 13-23, 2014 | 4 | 2014 |
| Phase I study of the novel anti-cancer drug PM00104 as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors or lymphoma SC Soria, R Plummer, A Soto, C Massard, H Calvert, R Prados, E Angevin, ... 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2008 | 4 | 2008 |
| Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of AG-014447, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cancer patients (pts) WJ Sam, M Amantea, B Houk, C Jones, H Steinfeldt, B Hee, R Plummer, ... CANCER RESEARCH 66 (8), 2006 | 4 | 2006 |
| Giant offshore pumice deposit records a shallow submarine explosive eruption of ancestral Santorini T Druitt, S Kutterolf, TA Ronge, C Hübscher, P Nomikou, J Preine, ... Communications Earth & Environment 5 (1), 24, 2024 | 3 | 2024 |
| Dynamics of sedimentation processes and their impact on biogeochemical reactions on the continental slope off Argentina and Uruguay (MARUM), Cruise No. SO260/Leg 1 & Leg2, Leg … S Kasten, T Schwenk, DA Aromokeye, M Baques, KH Baumann, ... SONNE-Berichte, 2019 | 3 | 2019 |
| Data report: pore water and solid-phase trace element distribution in sediments from IODP Expedition 334 Sites U1378 and U1379 CK Jones, N Riedinger, TW Lyons, ME Torres Proceedings of the IODP, 2021 | 1 | 2021 |
| Local controls on marine silicate weathering and alkalinity production in surface sediments from the Argentine Basin CK Jones, N Riedinger, ME Torres, TW Lyons 2024 Goldschmidt Conference, 2024 | | 2024 |
Natascha RiedingerOklahoma State UniversityVerified email at okstate.edu
